Related references
Note: Only part of the references are listed.Recent advances in the understanding of enterovirus A71 infection: a focus on neuropathogenesis
Han Kang Tee et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2021)
Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors
Chunlong Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Epidemiological dynamics of enterovirus D68 in the United States and implications for acute flaccid myelitis
Sang Woo Park et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses
Yanmei Hu et al.
ACS INFECTIOUS DISEASES (2021)
The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor
Yanmei Hu et al.
EMERGING MICROBES & INFECTIONS (2021)
Recent progress and challenges in drug development to fight hand, foot and mouth disease
Ze Qin Lim et al.
EXPERT OPINION ON DRUG DISCOVERY (2020)
Acute Flaccid Myelitis: A Clinical Review
Olwen C. Murphy et al.
SEMINARS IN NEUROLOGY (2020)
Enterovirus and Encephalitis
Bo-Shiun Chen et al.
FRONTIERS IN MICROBIOLOGY (2020)
Enterovirus D68 Antivirals: Past, Present, and Future
Yanmei Hu et al.
ACS INFECTIOUS DISEASES (2020)
Development of broad-spectrum enterovirus antivirals based on quinoline scaffold
Rami Musharrafieh et al.
BIOORGANIC CHEMISTRY (2020)
Pharmacological Characterization of the Mechanism of Action of R523062, a Promising Antiviral for Enterovirus D68
Chunlong Ma et al.
ACS INFECTIOUS DISEASES (2020)
The Structure, Function, and Mechanisms of Action of Enterovirus Non-structural Protein 2C
Shao-Hua Wang et al.
FRONTIERS IN MICROBIOLOGY (2020)
Rational design of highly potent broad-spectrum enterovirus inhibitors targeting the nonstructural protein 2C
Lisa Bauer et al.
PLOS BIOLOGY (2020)
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against Mpro and cathepsin L
Michael Dominic Sacco et al.
SCIENCE ADVANCES (2020)
Enterovirus infection and acute flaccid myelitis
Priyanka Uprety et al.
CURRENT OPINION IN VIROLOGY (2020)
Discovery of Quinoline Analogues as Potent Antivirals against Enterovirus D68 (EV-D68)
Rami Musharrafieh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Acute Flaccid Myelitis: Something Old and Something New
David M. Morens et al.
MBIO (2019)
Fluoxetine Inhibits Enterovirus Replication by Targeting the Viral 2C Protein in a Stereospecific Manner
Lisa Bauer et al.
ACS INFECTIOUS DISEASES (2019)
Understanding Enterovirus D68-Induced Neurologic Disease: A Basic Science Review
Alison M. Hixon et al.
VIRUSES-BASEL (2019)
Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid Myelitis
Nischay Mishra et al.
MBIO (2019)
A Novel Capsid Binding Inhibitor Displays Potent Antiviral Activity against Enterovirus D68
Chunlong Ma et al.
ACS INFECTIOUS DISEASES (2019)
Safety, tolerability, and efficacy of fluoxetine as an antiviral for acute flaccid myelitis
Kevin Messacar et al.
NEUROLOGY (2019)
Evaluation of antiviral therapies in respiratory and neurological disease models of Enterovirus D68 infection in mice
Brett L. Hurst et al.
VIROLOGY (2019)
Genomic Analyses of Acute Flaccid Myelitis Cases among a Cluster in Arizona Provide Further Evidence of Enterovirus D68 Role
Jolene R. Bowers et al.
MBIO (2019)
Antivirals and vaccines for Enterovirus A71
Jing-Yi Lin et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes
Jessica L. Dunne et al.
DIABETOLOGIA (2019)
The association between acute flaccid myelitis (AFM) and Enterovirus D68 (EV-D68) - what is the evidence for causation?
Amalie Dyda et al.
EUROSURVEILLANCE (2018)
Synthesis and Structure-Activity Relationship (SAR) Studies of Novel Pyrazolopyridine Derivatives as Inhibitors of Enterovirus Replication
Yanpeng Xing et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Enterovirus D68 and acute flaccid myelitis-evaluating the evidence for causality
Kevin Messacar et al.
LANCET INFECTIOUS DISEASES (2018)
The life cycle of non-polio enteroviruses and how to target it
Jim Baggen et al.
NATURE REVIEWS MICROBIOLOGY (2018)
The seasonality of nonpolio enteroviruses in the United States: Patterns and drivers
Margarita Pons-Salort et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Causation of Acute Flaccid Paralysis by Myelitis and Myositis in Enterovirus-D68 Infected Mice Deficient in Interferon/Receptor Deficient Mice
John D. Morrey et al.
VIRUSES-BASEL (2018)
Crystal structure of a soluble fragment of poliovirus 2CATPase
Hongxin Guan et al.
PLOS PATHOGENS (2018)
Contemporary Circulating Enterovirus D68 Strains Have Acquired the Capacity for Viral Entry and Replication in Human Neuronal Cells
David M. Brown et al.
MBIO (2018)
2-Year Efficacy, Immunogenicity, and Safety of Vigoo Enterovirus 71 Vaccine in Healthy Chinese Children: A Randomized Open-Label Study
Mingwei Wei et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Evaluating Treatment Efficacy in a Mouse Model of Enterovirus D68-Associated Paralytic Myelitis
Alison M. Hixon et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Direct-acting antivirals and host-targeting strategies to combat enterovirus infections
Lisa Bauer et al.
CURRENT OPINION IN VIROLOGY (2017)
A mouse model of paralytic myelitis caused by enterovirus D68
Alison M. Hixon et al.
PLOS PATHOGENS (2017)
Crystal structure of 2C helicase from enterovirus 71
Hongxin Guan et al.
SCIENCE ADVANCES (2017)
Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses
Yanmei Hu et al.
ANTIVIRAL RESEARCH (2017)
Discovery of Structurally Diverse Small-Molecule Compounds with Broad Antiviral Activity against Enteroviruses
Jun Zuo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Screening of a Library of FDA-Approved Drugs Identifies Several Enterovirus Replication Inhibitors That Target Viral Protein 2C
Rachel Ulferts et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Global emergence of enterovirus D68: a systematic review
Charlotte Carina Holm-Hansen et al.
LANCET INFECTIOUS DISEASES (2016)
EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases
Qunying Mao et al.
EMERGING MICROBES & INFECTIONS (2016)
Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Feng-Cai Zhu et al.
LANCET (2013)
Approach to the Library of Fused Pyridine-4-carboxylic Acids by Combes-Type Reaction of Acyl Pyruvates and Electron-Rich Amino Heterocycles
Dmitriy M. Volochnyuk et al.
JOURNAL OF COMBINATORIAL CHEMISTRY (2010)
Share Paper
